April 7, 2017

Panaxea hosts MedtechMeeting in Amsterdam

On 23rd of march 2017 Panaxea hosted the MedtechMeeting at the ‘Silicon Valley’ of Amsterdam: Science Park. This event was […]
February 22, 2017

Panaxea’s Janne Mewes about the importance of aftercare in cancer patients for employers

As the incidence of cancer is rising and more patients survive their disease, the number of people within the population […]
February 22, 2017

The economics of bringing precision medicine to the clinic

Precision Medicine’s value is undeniable. But what about its financial impact? And how should we assess its value? Read the […]
February 6, 2017

Digital health innovations: assessment of their impact on health and economic outcomes

With the ageing population in Europe, an increase in the number of people with chronic diseases, limited health care budgets […]
October 4, 2016

Integrated care: unlocking the mysteries

Mystery is not a word that we often connect with health and care as these are worlds in which we […]
August 25, 2016

The broader view of health economics

Thermo Fisher is a long time client of Panaxea. This resulted among others in a tailor made health economic model […]
August 23, 2016

The challenges and opportunities of articulating the value of your diagnostics

We added a new white paper about the challenges and opportunities of articulating the value of your diagnostics! Please click […]
June 20, 2016

MAFEIP follow up: Panaxea joins European Innovation Partnership on Active and Healthy Ageing Action Groups

Following an earlier involvement with the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA), Panaxea is now a […]
June 20, 2016

Further research for predictive biomarkers

Lotte Steuten worked along with Anna Miquel-Cases, Valesca Retèl, and Wim van Harten on a paper on decision about design […]